# US 2023/0414134 A1 · Encapsulation device systems with oxygen sensors with or without exogenous oxygen delivery

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0414134 A1
- Document ID: US20230414134A1
- Status: Published application
- Kind: A1
- Application number: 18/225,504
- Filed: 2023-07-24
- Published: 2023-12-28
- Earliest claimed: 2016-11-03
- Assignees: Arizona Board of Regents on Behalf of the University of Arizona
- Applicants: Arizona Board of Regents on Behalf of the University of Arizona
- Inventors: Klearchos K. Papas
- Web page: https://patentgrep.com/patent/US20230414134A1

## CPC

- A61B 5/14503: {invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors (A61B5/1459, A61B5/1464, A61B5/1473, A61B5/1482, A61B5/14865 take precedence)}
- A61B 5/0031: {Implanted circuitry}
- A61B 5/14532: {for measuring glucose, e.g. by tissue impedance measurement}
- A61B 5/14539: {for measuring pH}
- A61B 5/14542: {for measuring blood gases (A61B5/14551 takes precedence)}
- A61B 5/14546: {for measuring analytes not otherwise provided for, e.g. ions, cytochromes}
- A61B 5/14551: {for measuring blood gases}
- A61B 5/4836: {Diagnosis combined with treatment in closed-loop systems or methods (A61B5/0036 takes precedence)}
- A61B 5/686: {Permanently implanted devices, e.g. pacemakers, other stimulators, biochips (A61B5/6861 takes precedence)}
- A61F 2/022: {Artificial gland structures using bioreactors (hemodialysis A61M1/16; hemofiltration A61M1/34; other extracorporeal blood treatment A61M1/36)}
- A61M 5/14: Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61B 5/1473: invasive, e.g. introduced into the body by a catheter
- A61B 5/14865: {invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

An encapsulation device system for therapeutic applications such as but not limited to regulating blood glucose. The system may comprise an encapsulation device with a first oxygen sensor integrated inside the device and a second oxygen sensor disposed on an outer surface of the device, wherein the sensors allow for real-time measurements (such as oxygen levels) related to cells (e.g., islet cells, stem cell derived beta cells, etc.) housed in the encapsulation device. The system may also feature an exogenous oxygen delivery system operatively connected to the encapsulation device via a channel, wherein the exogenous oxygen delivery system is adapted to deliver oxygen to the encapsulation device.

## Claims

### Claim 1

An implantable encapsulation device for housing cells, the device comprising:
a lumen for receiving and housing cells;
a vascularization membrane at least partially surrounding the lumen, and wherein the vascularization membrane is permeable to cells and comprises pores of less than 10 micrometers;
an immuno-isolation membrane provided adjacent the vascularization membrane and wherein the immuno-isolation membrane comprises smaller pores than the vascularization membrane;
an oxygen delivery system and a gas channel operable to deliver gas to the device;
a sensor provided in the device; and
wherein the sensor is operable to determine at least one of an oxygen level and an oxygen consumption rate.

### Claim 2 (depends on 1)

The device of claim 1, wherein the sensor comprises at least one of an optical sensor, an electrochemical sensor, and a nuclear magnetic resonance-based sensor.

### Claim 3 (depends on 1)

The device of claim 1, wherein the sensor is provided within the gas channel.

### Claim 4 (depends on 1)

The device of claim 1, wherein the device comprises a cell loading port that provides access to the lumen.

### Claim 5 (depends on 1)

The device of claim 1, further comprising a reader adapted to communicate with the sensor.

### Claim 6 (depends on 5)

The device of claim 5, wherein the reader comprises a wireless reader provided external to the lumen and operable to be provided external to the skin of a patient.

### Claim 7 (depends on 1)

The device of claim 1, wherein the sensor is selected from the group comprising: oxygen sensors, glucose sensors, pH sensors, lactate sensors, carbon dioxide sensors, optical sensors, and electrochemical sensors.

### Claim 8

An implantable encapsulation device for housing cells, the device comprising:
a lumen for receiving and housing cells;
a vascularization membrane at least partially surrounding the lumen, and wherein the vascularization membrane is permeable to cells;
a sensor provided within the lumen or on the vascularization membrane;
wherein the sensor is operable to detect vascularization within the device based on at least one of oxygen level and an oxygen consumption rate.

### Claim 9 (depends on 8)

The device of claim 8, further comprising a second sensor and wherein the first sensor and the sensor are spaced apart by a physical distance and are operable to determine at least one of: oxygen centration at different locations, and oxygen consumption rate over the physical distance.

### Claim 10 (depends on 8)

The device of claim 8, further comprising an immuno-isolation member provided adjacent to the vascularization membrane.

### Claim 11 (depends on 8)

The device of claim 8, wherein the device comprises a cell loading port that provides access to the lumen.

### Claim 12 (depends on 9)

The device of claim 9, further comprising a reader adapted to read at least one of the first sensor and the second sensor.

### Claim 13 (depends on 12)

The device of claim 12, wherein the reader comprises a wireless reader provided external to the lumen and operable to be provided external to the skin of a patient.

### Claim 14 (depends on 8)

The device of claim 8, further comprising an oxygen delivery system comprising an implantable oxygen generator and a microprocessor that is operable to regulate oxygen delivery from the oxygen delivery system to the lumen.

### Claim 15

A method for detecting vascularization of an implantable device, the method comprising:
providing an implantable device comprising a lumen for receiving and housing cells; a vascularization membrane at least partially surrounding the lumen, and wherein the vascularization membrane is permeable to cells; a first sensor and a second sensor;
monitoring a first oxygen level at a first location of the implantable device by reading the first sensor;
monitoring a second oxygen level at a second location of the implantable device by reading the second sensor;
determining at least one of an oxygen concentration and oxygen consumption rate; and wherein vascularization is detected or determined based on at least one of the oxygen consumption rate and oxygen concentration.

### Claim 16 (depends on 15)

The method of claim 15, wherein a microprocessor and an oxygen delivery system are provided, and wherein the microprocessor commands the oxygen delivery system to increase oxygen delivery to the implantable device based on the oxygen concentration or the oxygen consumption rate.

### Claim 17 (depends on 15)

The method of claim 15, further comprising providing a wireless reader on a patient's skin.

### Claim 18 (depends on 15)

The method of claim 15, wherein at least one of the first sensor and the second sensor is selected from the group comprising: oxygen sensors, glucose sensors, pH sensors, lactate sensors, carbon dioxide sensors, optical sensors, and electrochemical sensors.

### Claim 19 (depends on 15)

The method of claim 15, wherein at least one of the sensors is provided within the lumen.

### Claim 20 (depends on 15)

The method of claim 15, wherein at least one of the first sensor and the second sensor comprises at least one of an optical sensor, an electrochemical sensor, and a nuclear magnetic resonance-based sensor.
